[{"id":"abad0806-f54e-4f8b-88af-6374bf415a5a","acronym":"","url":"https://clinicaltrials.gov/study/NCT02650193","created_at":"2021-01-18T12:54:01.849Z","updated_at":"2024-07-02T16:37:05.837Z","phase":"Phase 2","brief_title":"A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.","source_id_and_acronym":"NCT02650193","lead_sponsor":"Pfizer","biomarkers":" CD34","pipe":"","alterations":" ","tags":["CD34"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Neupogen (filgrastim) • Nyvepria (pegfilgrastim-apgf)"],"overall_status":"Completed","enrollment":" Enrollment 25","initiation":"Initiation: 12/01/2015","start_date":" 12/01/2015","primary_txt":" Primary completion: 10/01/2017","primary_completion_date":" 10/01/2017","study_txt":" Completion: 10/01/2017","study_completion_date":" 10/01/2017","last_update_posted":"2018-10-23"}]